Advances in molecular adjuvants for nucleic acid vaccines
As nucleic acid vaccine technology continues to advance, modern adjuvants are being engineered to quantitatively and qualitatively shape immune responses. Since their development in the early 1990’s, nucleic acid approaches have garnered significant at…